Kintegral Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $674K | Sell |
|
|||||
|
2025
Q2 | $632K | Sell |
|
|||||
|
2025
Q1 | $765K | Sell |
|
|||||
|
2024
Q4 | $862K | Sell |
|
|||||
|
2024
Q3 | $1.33M | Sell |
|
|||||
|
2024
Q2 | $1.35M | Buy |
|
|||||
|
2024
Q1 | $656K | Sell |
|
|||||
|
2023
Q4 | $601K | Sell |
|
|||||
|
2023
Q3 | $566K | Hold |
|
|||||
|
2023
Q2 | $494K | Hold |
|
|||||
|
2023
Q1 | $565K | Sell |
|
|||||
|
2022
Q4 | $523K | Sell |
|
|||||
|
2022
Q3 | $664K | Hold |
|
|||||
|
2022
Q2 | $570K | Buy |
|
|||||
|
2022
Q1 | $659K | Buy |
|
|||||
|
2021
Q4 | $582K | Hold |
|
|||||
|
2021
Q3 | $558K | Hold |
|
|||||
|
2021
Q2 | $515K | Hold |
|
|||||
|
2021
Q1 | $436K | Hold |
|
|||||
|
2020
Q4 | $445K | Hold |
|
|||||
|
2020
Q3 | $516K | Sell |
|
|||||
|
2020
Q2 | $594K | Hold |
|
|||||
|
2020
Q1 | $465K | Buy |
|
|||||
|
2019
Q4 | $317K | Hold |
|
|||||
|
2019
Q3 | $234K | Hold |
|
|||||
|
2019
Q2 | $264K | Hold |
|
|||||
|
2019
Q1 | $347K | Buy |
|
|||||
|
2018
Q4 | $302K | Buy |
|